scispace - formally typeset
D

Dino Alberico

Researcher at University of Toronto

Publications -  36
Citations -  4144

Dino Alberico is an academic researcher from University of Toronto. The author has contributed to research in topics: Aryl & Alkylation. The author has an hindex of 14, co-authored 36 publications receiving 3941 citations. Previous affiliations of Dino Alberico include Université de Montréal.

Papers
More filters
Journal ArticleDOI

Catalytic Asymmetric Synthesis of Nitrocyclopropane Carboxylates.

TL;DR: The cyclopropanation of an iodonium ylide derived from methyl nitroacetate (II) in the presence of chiral copper complexes leads to a variety of trans-nitrocyclopronane carboxylates with up to 95% diastereoselectivity and up to 98% e.g.
Journal ArticleDOI

Palladium-Catalyzed Ring-Forming Reactions: Methods and Applications

TL;DR: Several Pd-catalyzed cyclization methods were developed, including norbornene- mediated Catellani-type reactions, a pd-caralyzed coupling reaction of aryl iodides and allyl moieties, and a tandem C-N/C-C coupling of gem-dihalovinyl systems.
Reference EntryDOI

Bicyclo[2.2.1]hept‐2‐ene (norbornene)

TL;DR: InChIKey as mentioned in this paper is a colorless solid; widely available; it can be used for storage and storage in a well-ventilated fume hood and distilled or purified by sublimation in vacuo onto an ice cold finger.
Journal ArticleDOI

Palladium‐Catalyzed Sequential Alkylation—Alkenylation Reactions: Application Towards the Synthesis of Polyfunctionalized Fused Aromatic Rings.

TL;DR: In this paper, the synthesis of polyfunctionalized fused aromatic carbo-and heterocycles from aryl iodides and bromoenoates via a tandem palladium-catalyzed aromatic substitution intramolecular Heck sequence is reported.
Patent

Procédé de synthèse pour la préparation d'analogues c1-céto macrocycliques de l'halichondrine b et intermédiaires utiles dans la synthèse, notamment des intermédiaires contenant des groupes -so2-(p-tolyle)

TL;DR: In this paper, an innovation concerne un compose de formule 1, ou un sel pharmaceutiquement acceptable dudit compose, dans lequel R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 7', R 8, R 9, R 10, R 11, R 12, R 14, R 15, R 16, R 17, R 18, R 19, R 20, R 21, R 22, R 23, R 24, R 25, R 26,